NEWPORT BEACH, Calif., April 25, 2014 /PRNewswire/ -- ALPHAEON Corporation, a leader in lifestyle healthcare and subsidiary of Strathspey Crown Holdings LLC, announced today that Bob Rhatigan has joined the company as Chief Operating Officer. In his new position, Mr. Rhatigan will play a key role in the development of ALPHAEON's commercial execution and future growth.
"I am delighted to welcome such an accomplished innovator and leader to the ALPHAEON team," said ALPHAEON Chief Executive Officer Robert E. Grant. "Bob has an outstanding track record of successful business leadership in medical aesthetics and will add tremendous value as ALPHAEON continues its rapid expansion to become the leader in providing innovative products and services in the lifestyle healthcare market."
Mr. Rhatigan spent the last 17 years at Allergan Inc., where he most recently served as Senior Vice President, General Manager and Chief Executive of SkinMedica® Inc. In this position, Mr. Rhatigan was responsible for the integration of SkinMedica into Allergan, Inc. and led all aspects of the global SkinMedica business, including research and development, commercialization, manufacturing and operations. Prior to this role, Mr. Rhatigan served as Senior Vice President of Allergan Inc.'s Facial Aesthetics business, where he led the launches and marketplace success of BOTOX® COSMETIC, JUVEDERM® and LATISSE® in the United States. Under his leadership, Allergan's Facial Aesthetics business received the highest customer satisfaction rating in medical aesthetics for seven consecutive years. Prior to Allergan, Mr. Rhatigan spent nine years at Procter and Gamble in a variety of roles of increasing responsibility in sales and marketing.
"Rhatigan's success in developing leading brands in the medical aesthetics arena will be a great complement to ALPHAEON as we continue to deliver innovative technologies and programs in lifestyle healthcare," said Robert E. Grant, Chief Executive Officer of ALPHAEON.
About ALPHAEON Corporation
ALPHAEON Corporation is a lifestyle healthcare company committed to partnering with board-certified physicians to bring to market and develop highly innovative technologies and services that promote patient wellness, beauty and performance. Ensuring access to leading advancements in lifestyle healthcare, the company fosters deep relationships with leading specialty physicians so patients look their best, feel their best and know they are receiving the best in lifestyle healthcare. For more information, please visit www.alphaeon.com.
About Strathspey Crown
Strathspey Crown is a growth equity firm specializing in lifestyle healthcare. Strathspey Crown uniquely partners with board certified physician specialists to bring to market highly innovative technologies and services in the self-pay sector. The firm is founded in partnership with physician investors across three key medical specialties: plastic surgery, ophthalmology and dermatology. For more information, visit www.strathspeycrown.com.
Jenna Mons, Vice President of Marketing and Communications
ALPHAEON™ is a trademark of ALPHAEON
SkinMedica®, JUVEDERM® BOTOX® COSMETIC and LATISSE® are registered trademarks of Allergan, Inc.
SOURCE ALPHAEON Corporation